Pitt Shield

Biological effects of rapid short pulses of focused ultrasound for drug delivery to the brain.

Authors: Morse SV, Rimer S, Geoghegan G, Shah M, Chan N, Yalcin C, Pereira MA, Rohfleisch L, Nkontchou N, Winiarski S, Ee J, Maitra A, Chan TG, Sastre M, Choi JJ

Focused ultrasound in combination with intravenously injected microbubbles offers a non-invasive and localised method to deliver drugs across the blood-brain barrier, enabling targeted treatment of brain disorders. Recently, we have shown that applying sequences of Rapid Short-Pulses (RaSP; 5 μs pulses emitted at 1.25 kHz grouped into 10 ms bursts) of ultrasound can deliver drugs with an improved efficacy and safety profile compared with traditionally-used longer pulses (> 10 ms). In this study, we examined the extent to which RaSP sequences allowed the extravasation of endogenous blood proteins, including albumin and immunoglobulin, as well as T cells, into the brain parenchyma. We also investigated the effect of RaSP ultrasound treatments on synaptic connectivity, and the distribution and excretion of fluorescently-labelled 3 kDa dextran delivered to the brain with RaSP. The left hippocampus of mice was sonicated with either a RaSP sequence (5 μs at 1.25 kHz in groups of 10 ms at 0.5 Hz) or a long pulse sequence (10 ms at 0.5 Hz), at 0.35, 0.53 and 0.71 MPa with a 1-MHz center frequency. Significantly less albumin was detected in RaSP-treated brains immediately after treatment and was cleared within 10 min compared to those treated with long pulses, while immunoglobulin was hardly detected in RaSP-treated brains at 0, 10 or 20 min after treatment. No T cells were detected in RaSP-treated brains at 0.35, 0.53 or 0.71 MPa after 0 or 2 h. In long pulse samples, however, T cells did extravasate when using the two higher acoustic pressures, 0.53 and 0.71 MPa, immediately after treatment. Quantification of dendritic spine area revealed no differences between RaSP-treated hippocampi compared to untreated contralateral hippocampi and control mice following three weekly ultrasound treatments. Finally, fluorescently-labelled dextran increasingly moved towards blood vessels and away from the parenchyma once delivered to the brain with both RaSP and long pulse sequences. Uptake of dextran within cells decreased over time with both sequences, and long pulses lead to a larger number of vessels with dextran uptake. This study highlights that RaSP ultrasound sequences can deliver molecules across the blood-brain barrier with minimal extravasation of endogenous proteins and no T cell infiltration, while preserving dendritic spine integrity, thus offering an improved safety profile.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To evaluate the biological effects of rapid short pulses of focused ultrasound intended to enhance drug delivery to the brain.
Animal model / Human subject mouse, not specified, not specified, not specified
Disease model healthy
MRI or image guidance method not reported
Targeted brain region(s) Hippocampus

Outcomes and Safety

Summary of Outcomes The study evaluated biological effects of rapid short pulses of FUS for drug delivery
Duration of biological effect 10 min
Safety-related matter No tissue damage reported.

Brain Region

Ultrasound Parameters

Ultrasound instrument not reported
FUS Frequency 1 MHz
FUS Intensity not reported
FUS Pressure 0.35–0.71 MPa
FUS Mode pulsed
Pulse duration 5 µs
Duration of a single FUS session not reported
Treatment frequency multiple sessions

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search